My Legacy Advisors’s Gilead Sciences GILD Stock Holding History

My Legacy Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$360K	Buy	+3,143	New	+$334K	0.13%	159
2024 Q1	–	Sell	-15,210	Closed	-$1.3M	–	216
2023 Q4	$1.3M	Buy	15,210 +254	+2%	+$19.8K	0.47%	57
2023 Q3	$1.17M	Buy	14,956 +278	+2%	+$21.4K	0.48%	62
2023 Q2	$1.13M	Sell	14,678 -294	-2%	-$23.4K	0.44%	64
2023 Q1	$1.24M	Buy	14,972 +360	+2%	+$29.8K	0.53%	57
2022 Q4	$1.23M	Buy	14,612 +1,250	+9%	+$99K	0.53%	54
2022 Q3	$884K	Buy	13,362 +5,108	+62%	+$322K	0.45%	69
2022 Q2	$517K	Buy	+8,254	New	+$511K	0.26%	141

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

My Legacy Advisors's GILD Position: Q2 2025 in Review

My Legacy Advisors opened a new position in Gilead Sciences (GILD) in Q2 2025: 3,143 shares worth $360K. The stake represents 0.13% of the portfolio and ranks #159 among its holdings. This is a return to the name: My Legacy Advisors previously reported a position in GILD as recently as Q4 2023.

My Legacy Advisors first reported a position in GILD in Q2 2022 and has held it in 8 quarters since. The position peaked at $1.3M in Q4 2023. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

My Legacy Advisors held 3,143 shares of Gilead Sciences worth $360K as of Q2 2025.
Gilead Sciences was a new My Legacy Advisors position in Q2 2025.
Gilead Sciences made up 0.13% of My Legacy Advisors's portfolio in Q2 2025, its #159 holding.
My Legacy Advisors first reported a position in Gilead Sciences in Q2 2022 and has held it in 8 quarters since.
My Legacy Advisors's Gilead Sciences position peaked at $1.3M in Q4 2023.
2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on My Legacy Advisors's 13F filing for Q2 2025, filed 11 Jul 2025.